[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

UCLA Jonsson Comp Cancer Center, Los Angeles, California, United States

MD Anderson Cancer Center, Houston, Texas, United States

Novartis Investigative Site, Shanghai, China

Novartis Investigative Site, Saint-Cloud, Hauts De Seine, France

Novartis Investigative Site, Bordeaux, France

Novartis Investigative Site, Saint-Herblain, France

Novartis Investigative Site, Cologne, North Rhine-Westphalia, Germany

Novartis Investigative Site, Gliwice, Poland

Novartis Investigative Site, Porto, Portugal

Novartis Investigative Site, L'Hospitalet de Llobregat, Barcelona, Spain

Novartis Investigative Site, Barcelona, Spain

Novartis Investigative Site, Madrid, Spain

Novartis Investigative Site, Madrid, Spain